Shafarman Consulting uses standard information models, such as the HL7 Reference Information Model (RIM) and the associated bindings of standard terminologies to understand and resolve interoperability issues. Encouraging and enabling the adoption of healthcare information standards that will support regional, national and international cross-enterprise sharing of healthcare data without loss of meaning is also a major focus. Principal Mark Shafarman MS BA has been a member of HL7 for over 20 years and was its Chairman 2004-05.
● Consulting and expert advice to the Healthcare industry
Membership in Professional Associations/Societies:
● HL7 Global ● HL7 Australia ● ...
Health Level 7 News
Health Level Seven and TransCelerate BioPharma Working Together to Facilitate Use of eSource for Clinical Research with HL7® FHIR®
Sunday, 3rd December 2017
Health Level Seven® (HL7®) International, the global authority on interoperability of health information technology with members in 55 countries, and TransCelerate BioPharma Inc., a non-profit organization to improve the health of people around the world by simplifying and accelerating the research and development of innovative new therapies, are working together to advance the use of eSource in clinical trials and facilitate interoperability by enabling the use of electronic health records (EHRs) in clinical research, enabled by the use of the HL7® FHIR® platform standard.
Health Level Seven Announces New Board Members, Fellows and Volunteer of the Year Awards
Tuesday, 12th September 2017
San Diego, CA – September 13, 2017 – Health Level Seven® (HL7®) International, the global authority on interoperability of health information technology with members in 55 countries, today announced election results for its Board of Directors and Technical Steering Committee at the 31st Annual Plenary and Working Group Meeting in San Diego, CA. The 2017 HL7 Fellows and the 2017 recipients of the W. Edward Hammond, PhD, Volunteer of the Year Awards were also recognized at the event.
HL7 Publishes First Domain Analysis Model for Clinical Sequencing
Sunday, 9th April 2017
Health Level Seven® International (HL7®), the global authority for interoperability in healthcare information technology and the home of the Fast Healthcare Interoperability Resources (FHIR®) standard, today announced that it has published the HL7 Domain Analysis Model: Clinical Sequencing, a model which captures precision medicine's use cases to facilitate interoperability of genetic and genomic data. This domain analysis model (DAM) was the basis for the design of FHIR Genomics, the genomics components designed under purview of the HL7 Clinical Genomics Work Group within FHIR Release 3. The DAM has also served as the foundation for underlying use cases selected for the Sync for Genes (www.sync4genes.org) program.
Could not find the News you were looking for? Search here: